Fida Biosystems

Fidabio’s platform provides detailed information on affinity (Kd), kinetics (kon & koff) size, concentration, stoichiometry, conformational changes, oligomeric state, immunogenicity, and multiple binding events — directly in complex biological samples such as plasma, serum, cell lysate, or fermentation media.

Fida Biosystems has raised €5.0M across 1 funding round from 2 investors, most recently a round in Dec 2025. Based in Soborg, Denmark; active in Healthtech. Data as of 28 Oct 2026.